semaglutide and dementia Two of the most anticipated studies this year—large-scale, randomized, controlled, double-blinded trials of the popular obesity and diabetes drug for Alzheimer's disease—have unfortunately ended in a dud. An oral version GLP-1 Drugs Linked to Lower
Description
they get pulled into the artery wall

The company references "Patented NanoNAD+ Technology" for both products

GLP-1 receptors demonstrate widespread but selective distribution throughout the central nervous system

However, if semaglutide unmasked a pre-existing GERD tendency, some degree of reflux may persist

Clinical Effectiveness: What Real-World Results Look Like with Phentermine Most patients can expect 35% body weight loss within the first 12 weeks, with the majority of weight reduction occurring early

The reason isnt efficacy, the trial data is exceptionally strong
